SMAD4 and neoplasm: For example, in patients undergoing pancreaticoduodenectomy, SMAD4 expression predicted improved survival even when adjusted to other prognostic factors including stage, tumor size, surgical margins, lymph node status, and the use of adjuvant chemoradiotherapy [32].